Related Experiment Videos
Clonazepam pharmacokinetics, brain uptake, and receptor interactions
D J Greenblatt1, L G Miller, R I Shader
1Department of Psychiatry, Tufts University School of Medicine, Boston, MA.
The Journal of Clinical Psychiatry
|October 1, 1987
Summary
Clonazepam is absorbed well orally and distributes into the brain, with its effects directly linked to receptor occupancy. Its unique clinical profile isn't due to unusual pharmacokinetics or receptor interactions.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Clonazepam is a 7-nitrobenzodiazepine derivative.
- Its pharmacokinetic and pharmacodynamic properties are crucial for understanding its clinical effects.
Purpose of the Study:
- To elucidate the pharmacokinetic and pharmacodynamic profile of clonazepam.
- To investigate the relationship between clonazepam concentration, receptor binding, and behavioral effects.
Main Methods:
- Analysis of clonazepam biotransformation pathways (nitroreduction, acetylation).
- Determination of absorption, distribution, and elimination half-life.
- In vitro receptor binding assays and in vivo brain-plasma concentration studies.
Main Results:
- Clonazepam undergoes nitroreduction and acetylation; metabolites lack significant activity.
- Oral absorption exceeds 80% with a half-life of 20-80 hours.
- Passive diffusion into the brain occurs, maintaining a constant brain-plasma ratio without sequestration.
- High in vitro receptor affinity correlates directly with in vivo receptor occupancy and behavioral effects.
Conclusions:
- Clonazepam's clinical profile is not explained by unique pharmacokinetic properties or distinct receptor interactions.
- Its therapeutic effects are predictably linked to brain concentration and benzodiazepine receptor occupancy.